论文信息 - Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer. - 字舞流文

Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer.

Terry L. Smith | G. Hortobagyi | L. Pusztai | N. Sneige | V. Valero | D. Booser | J. Murray | B. Esmaeli | F. Esteva | B. Arun | M. Cristofanilli | H. Fritsche | L. Guerra | T. Smith